Among the four anti-VEGF agents (ranibizumab, bevacizumab, pegaptanib, and aflibercept), ranibizumab is the one most thoroughly studied (eg, DRCR.net, RISE, RIDE, RESTORE, READ-2, RESOLVE).
Quiz Module 9.4
To validate your answers and keep track of your progress please sign in or register a new account
1. Which of the anti-VEGF agents used for DME has been the most thoroughly studied?
2. Which of the following is not correct?
3. Which of the following studies demonstrated the efficacy and safety of ranibizumab for the treatment of DME?